Dr. Oleg Gligich is a board-certified oncologist at Mount Sinai Medical Center. Dr. Gligich graduated Magna Cum Laude with a bachelor’s degree in biology and chemistry from Hunter College in Manhattan with a focus on cancer biology and microenvironment. He earned his medical degree from Ross University School of Medicine with honors and went on to complete his residency in internal medicine at Jacobi Medical Center in New York City. He completed a fellowship in hematology and oncology at the renowned Albert Einstein College of Medicine – Montefiore Medical Center in New York City.

Prior to joining Mount Sinai, Dr. Gligich cared for patients at a multidisciplinary cancer treatment center in Tampa where he was at the forefront of clinical trial initiatives while spearheading areas of patient safety improvement, cost-saving initiatives, and resident academics.

While completing his fellowship, Dr. Gligich, working with the leading experts in breast cancer research including Dr. Joseph Sparano. He has authored multiple publications, abstracts, and posters in areas of breast and hematologic oncology. Throughout his education, he participated in a wide variety of clinical activities and volunteering experience with the American Cancer Society, Memorial Sloan Kettering Cancer Center and Menorah Home & Hospital in New York City. Dr. Gligich is a member of the American Society of Clinical Oncology and the American Society of Hematology.

He is fluent in Russian and conversational Spanish.

Areas of Clinical Interest: 

• Lung cancer
• Breast cancer and clinical trial development
• Genitourinary oncology; Prostate, Kidney and Bladder Cancer
• Targeted therapeutics
• Immunotherapy

*This physician is employed by Mount Sinai Medical Center

Selected Publications:

• Comparison of survival and clinic pathological features between patients with breast cancer and HIV infection versus breast cancer without HIV infection. Cancer Res (2017) 77 (4_Supplement): P2-07-07.
• Time differences in breast cancer diagnosis among minorities in a large referral academic center. Cancer Res (2017) 77 (4_Supplement): P5-10-05.
• Breast Cancer in patients with Human Immunodeficiency Virus (HIV) infection: The Bronx experience. International Conference on Malignancies in AIDS and Other Acquired immunodeficiencies. National Institute of Health, Bethesda, MD. October 2015, National Institute of Health, Bethesda, MD.
• Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies. Annals of Hematology. 2016 Mar 95(4):575-80.
• Elderly woman with sharp shoulder pain, a presentation of mesothelioma. Journal of Family Practice. 2016 May;65(5):345-347.
• Retrospective study of the prevalence and progression of monoclonal gammopathy in HIV positive versus HIV negative patients. Hematological Oncology. 2015 Jul 24.
• High-resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. Journal of Biological Chemistry. 2013 Mar 29;288(13):8805-14.
• Signal Transduction Inhibitors as novel therapy in the Treatment of Myelodysplastic Syndrome Journal of Hematology & Oncology. 2013 July 10.
• Retrospective Exploratory Study of HIV+ Patients with and without Paraproteinemia for Association with HIV Status, Comorbidities and Development of Hematological Malignancies.” Society of Hematology, Dec 8, 2012.